pilocarpine has been researched along with dantrolene in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hadar, E; Rutecki, PA; Sayin, U; Yang, Y | 1 |
| Carter, DS; DeLorenzo, RJ; Deshpande, LS; Nagarkatti, N | 1 |
| Almeida, C; Andrade, KA; Dos Santos, BA; Higa, GSV; Kihara, AH; Kinjo, ER; Kostecki, DS; Royero, PX | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for pilocarpine and dantrolene
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 other study(ies) available for pilocarpine and dantrolene
| Article | Year |
|---|---|
Determinants of ictal epileptiform patterns in the hippocampal slice.
Topics: Animals; Calcium; Calcium Channels, L-Type; Dantrolene; Electrophysiology; Enzyme Inhibitors; Epilepsy; Excitatory Amino Acid Agonists; Glycine; Hippocampus; In Vitro Techniques; Male; Muscarinic Agonists; Neural Inhibition; Pilocarpine; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Receptors, Glutamate; Resorcinols; Thapsigargin | 2002 |
Dantrolene inhibits the calcium plateau and prevents the development of spontaneous recurrent epileptiform discharges following in vitro status epilepticus.
Topics: Animals; Calcium; Cell Death; Cells, Cultured; Dantrolene; Dizocilpine Maleate; Epilepsy; Excitatory Amino Acid Antagonists; Hippocampus; Muscarinic Agonists; Muscle Relaxants, Central; Neurons; Neuroprotective Agents; Patch-Clamp Techniques; Pilocarpine; Rats; Rats, Sprague-Dawley; Status Epilepticus | 2010 |
Ryanodine receptors drive neuronal loss and regulate synaptic proteins during epileptogenesis.
Topics: Animals; Calcium; Calcium Channel Blockers; Dantrolene; Hippocampus; Male; Neurons; Neuroprotective Agents; Pilocarpine; Rats; Rats, Wistar; Ryanodine Receptor Calcium Release Channel; Seizures; Status Epilepticus; Synapses; Synapsins; Synaptophysin | 2020 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |